4-Pyridinecarboxylic acid, 3-[[[(4R)-3,4-dihydro-7-[methyl[4-(1-methylethyl)phenyl]amino]-2H-1-benzopyran-4-yl]methyl]amino]- manufacturers
- Zavondemstat
-
- $136.00
-
2026-07-15
- CAS:1851412-93-5
- Purity: 99.41%
- Supply Ability: 10g
|
| | 4-Pyridinecarboxylic acid, 3-[[[(4R)-3,4-dihydro-7-[methyl[4-(1-methylethyl)phenyl]amino]-2H-1-benzopyran-4-yl]methyl]amino]- Basic information |
| | 4-Pyridinecarboxylic acid, 3-[[[(4R)-3,4-dihydro-7-[methyl[4-(1-methylethyl)phenyl]amino]-2H-1-benzopyran-4-yl]methyl]amino]- Chemical Properties |
| Boiling point | 692.5±55.0 °C(Predicted) | | density | 1.223±0.06 g/cm3(Predicted) | | pka | 1.55±0.36(Predicted) | | form | Solid | | color | Light yellow to yellow |
| | 4-Pyridinecarboxylic acid, 3-[[[(4R)-3,4-dihydro-7-[methyl[4-(1-methylethyl)phenyl]amino]-2H-1-benzopyran-4-yl]methyl]amino]- Usage And Synthesis |
| Description | Zavondemstat is a KDM4 inhibitor with potential as an antineoplastic agent. | | Uses | Zavondemstat (QC8222; TACH 101) is an inhibitor of histone lysine demethylase 4D (KDM4D) with antineoplastic activity[1]. | | References | [1] WHO Drug Information-World Health Organization (WHO). |
| | 4-Pyridinecarboxylic acid, 3-[[[(4R)-3,4-dihydro-7-[methyl[4-(1-methylethyl)phenyl]amino]-2H-1-benzopyran-4-yl]methyl]amino]- Preparation Products And Raw materials |
|